![Natacha Beaumont](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Natacha Beaumont
Directeur/Membre du Conseil chez
Finlight.Com Ltd.
Profil
Natacha Beaumont is currently an Executive Director at Finlight.
Com Ltd. She previously worked as a Non-Executive Director at Moleac Pte Ltd. and FORMAC Pharmaceuticals NV.
From 2007 to 2014, she was the Managing Director at Hunza Management SARL, where she held the title of Managing Director from 2011 to 2014.
She also worked as a Director at iTeos Therapeutics SA. Ms. Beaumont holds a graduate degree and an MBA from the Université Libre de Bruxelles.
Postes actifs de Natacha Beaumont
| Sociétés | Poste | Début |
|---|---|---|
Finlight.Com Ltd.
 Finlight.Com Ltd. Packaged SoftwareTechnology Services Provides asset management software solutions | Directeur/Membre du Conseil | - |
Anciens postes connus de Natacha Beaumont
| Sociétés | Poste | Fin |
|---|---|---|
Hunza Management SARL
 Hunza Management SARL Investment ManagersFinance Hunza is a venture capital investor focused on sectors including biotechnology, pharmaceuticals, medical technology and medical services. They also invest in high-tech industries such as software, energy, environmental technology, Internet and media. The firm targets companies with high-value creation potential and leverages their business experience, knowledge and networks to turn them into market leaders. They invest across development stages in seed, startup and expansion financing. Hunza invests globally through shareholder loans, majority or significant minority equity participations, mezzanine and bridge financing. Their investments have included traditional Chinese medicine, oncology, drug delivery technology and minimally-invasive medical devices for heart surgery. | Director of Investments | 31/03/2014 |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Directeur/Membre du Conseil | - |
Moleac Pte Ltd.
 Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes biopharmaceutical products | Directeur/Membre du Conseil | - |
FORMAC Pharmaceuticals NV
 FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology Engages in drug delivery and development services | Directeur/Membre du Conseil | - |
Formation de Natacha Beaumont
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FORMAC Pharmaceuticals NV
FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology Engages in drug delivery and development services | Health Technology |
Hunza Management SARL
Hunza Management SARL Investment ManagersFinance Hunza is a venture capital investor focused on sectors including biotechnology, pharmaceuticals, medical technology and medical services. They also invest in high-tech industries such as software, energy, environmental technology, Internet and media. The firm targets companies with high-value creation potential and leverages their business experience, knowledge and networks to turn them into market leaders. They invest across development stages in seed, startup and expansion financing. Hunza invests globally through shareholder loans, majority or significant minority equity participations, mezzanine and bridge financing. Their investments have included traditional Chinese medicine, oncology, drug delivery technology and minimally-invasive medical devices for heart surgery. | Finance |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Health Technology |
Finlight.Com Ltd.
Finlight.Com Ltd. Packaged SoftwareTechnology Services Provides asset management software solutions | Technology Services |
